If I may suggest, go and get very familiar with the technicalities and the vocabulary regarding everything covid19 and vaccines and testing protocols
Most people can't tell the difference between sars-cov2 and covid19 to begin with, so, without arguing with them about the vaccines effects and the pros and cons, if you can manage to school them on the basics already from the get go, correct them every time they make a technically false statement, you won already... You de facto impose yourself as the technical authority on the matter, you know what you're talking about they don't, it's a fact you don't even need to point out, to begin with
It can surely help to keep them at bay for a while, so they don't bring the topic on the table too often, because they remember that embarrassing moment last time they tried
Now of course if you're in a medical environment surrounded by professionals pro vax, that's different, it's going to be more difficult to insert yourself as a "technical authority", for obvious reasons
'Informed consent', due to the stage three (2 year) human trials still being undertaken, you're waiting for the study data to be fully completed, collated, analysed and released. So as to be fully informed in your decision, your still waiting for the 'actual science' of the Mrna 'jab' - you're following standard medical procedure by waiting for it to be fully authorised at the moment you decline to take an experimental medical treatment/ gene therapy for an ailment you 'provably' don't have. Thank them for the concern but i politely decline the medical advice of those that are not registered medical professionals or those that are who fail to inform me of it being experimental (with only Emergency Use Authorisation) and having no scientific data available for any potential long term risks completed yet.
When did this non FDA approved drug become a vaccine?
Non sequitur, the FDA approval is not required for a "drug"/product to qualify as vaccine
Coronavirus (COVID-19) Update
In mid-July, the FDA held a stakeholder call to discuss COVID-19 vaccines, including preliminary reports of Guillain-Barré Syndrome following Janssen (Johnson & Johnson) COVID-19 vaccination. Acting FDA Commissioner Janet Woodcock, M.D. and the Director of FDA's Center for Biologics Evaluation and Research, Peter Marks, M.D., Ph.D. were featured speakers. The call can be found on the FDA’s YouTube pageExternal Link Disclaimer.
COVID-19 Update
07/30/2021
Coronavirus (COVID-19) Update
On Wednesday, the FDA authorized an extension for the shelf life of the refrigerated Janssen (Johnson & Johnson) COVID-19 Vaccine, allowing the product to be stored at 2-8 degrees Celsius for six months.
COVID-19 Update
07/16/2021
Coronavirus (COVID-19) Update
The FDA formally accepts Priority Review designation for the Biologics License Application (BLA) for their mRNA vaccine to prevent COVID-19 in individuals 16 years of age and older.
Changing the rules to further the agenda
(post is archived)